Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP4A | P20648 | 15/20 | 0.62 |
| ▸ | ATP4B | P51164 | 15/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.62 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.62 |
| ▸ | FASN | P49327 | 1/20 | 0.62 |
| ▸ | SLC47A2 | Q86VL8 | 1/20 | 0.62 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.62 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.62 |
| ▸ | ATP1A1 | P05023 | 9/20 | 0.53 |
| ▸ | ATP1B1 | P05026 | 9/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pantoprazole SCHEMBL27634499 | 1.00 | ATP4A (0.62) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL15540468 | 0.99 | ATP4A (0.61) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL29463615 | 0.99 | ATP4A (0.63) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL22198 | 0.99 | ATP4A (0.63) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL723548 | 0.99 | ATP4A (0.63) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL30777582 | 0.99 | ATP4A (0.63) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL29530572 | 0.99 | ATP4A (0.63) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL29466 | 0.99 | ATP4A (0.63) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL1716779 | 0.98 | ATP4A (0.62) | ATP4AATP4BCYP2C9CYP3A4KDM4E | |
| Pantoprazole SCHEMBL3179782 | 0.98 | ATP4A (0.62) | ATP4AATP4BCYP2C9CYP3A4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2628 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036684-A | Preparation method of levorotatory pantoprazole sodium double-hemi-hydrate | 杭州中美华东制药有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-119798220-A | Preparation method of digestive drug intermediate | 山东罗欣药业集团恒欣药业有限公司 | 2025-04-11 | — | — | CN | claimed |
| WO-2025045191-A1 | PANTOPRAZOLE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海云晟研新生物科技有限公司 | 2025-03-06 | — | — | WO | claimed |
| CN-119548499-A | Pantoprazole pharmaceutical composition, preparation method and application thereof | 上海云晟研新生物科技有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-119064364-A | Pantoprazole sodium enteric capsule quality detection device | 湖南明瑞制药股份有限公司 | 2024-12-03 | — | — | CN | claimed |
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| US-20240238264-A1 | INHIBITORS OF SARM1 NADASE ACTIVITY AND USES THEREOF | DISARM THERAPEUTICS, INC. | 2024-07-18 | — | — | US | claimed |
| US-12005050-B2 | Methods for preventing or treating H. pylori infection | TENNOR THERAPEUTICS (SUZHOU) LIMITED (CN) | 2024-06-11 | — | — | US | claimed |
| CN-221038207-U | Pantoprazole sodium finished product sampling detection device for injection | 济南兴鲁医药科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117731664-B | Preparation and application of tumor MRI diagnosis and treatment integrated nano probe for acidosis monitoring | 山东第一医科大学(山东省医学科学院) | 2024-05-10 | — | — | CN | claimed |
| US-6383510-B1 | Suppository form comprising an acid-labile active compound | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 2002-05-07 | — | — | US | claimed |
| US-20020025342-A1 | Novel administration form comprising an acid-labile active compound | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH | 2002-02-28 | — | — | US | claimed |
| US-6328993-B1 | Oral administration form for an acid liable active proton pump inhibitor | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 2001-12-11 | — | — | US | claimed |
| CN-1318065-A | Novel salt form of pantoprazole | BYK GUILDEN LOMBERG CHEMISCHE (DE) | 2001-10-17 | — | — | CN | claimed |
| EP-1037607-A1 | NOVEL SUPPOSITORY FORM COMPRISING AN ACID-LABILE ACTIVE COMPOUND | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 2000-09-27 | — | — | EP | claimed |
| EP-1037634-A1 | NOVEL ADMINISTRATION FORM COMPRISING AN ACID-LABILE ACTIVE COMPOUND | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 2000-09-27 | — | — | EP | claimed |
| CN-1235018-A | Pantoprazole sodium freeze-dried powder injection and preparation method thereof | DONGYU PHARMACEUTICAL CO LTD S (CN) | 1999-11-17 | — | — | CN | claimed |
| WO-1999029320-A1 | NOVEL ADMINISTRATION FORM COMPRISING AN ACID-LABILE ACTIVE COMPOUND | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1999-06-17 | — | — | WO | claimed |
| WO-1999029299-A1 | NOVEL SUPPOSITORY FORM COMPRISING AN ACID-LABILE ACTIVE COMPOUND | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1999-06-17 | — | — | WO | claimed |
| CN-1037932-C | Method for preparing oral tablet and pill dosage form capable of tolerating gastric juice | BYR GULDEN LOMBERG CHEMISCHE G (DE) | 1998-04-08 | — | — | CN | claimed |